Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUSP3 | P51452 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.31 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17810053 | 0.81 | IDO1 (0.44) | DUSP3KDM4EATML3MBTL1ALKBH5 | |
| SCHEMBL17809879 | 0.80 | DUSP3 (0.44) | DUSP3KDM4EATML3MBTL1ALKBH5 | |
| SCHEMBL17809832 | 0.78 | DUSP3 (0.50) | DUSP3KDM4EATML3MBTL1ALKBH5 | |
| SCHEMBL17810113 | 0.78 | ALDH1A1 (0.43) | DUSP3KDM4EATML3MBTL1ALKBH5 | |
| SCHEMBL17810052 | 0.78 | DUSP3 (0.42) | DUSP3KDM4EATML3MBTL1ALKBH5 | |
| SCHEMBL17810065 | 0.78 | SMARCA2 (0.44) | DUSP3KDM4EATML3MBTL1 | |
| SCHEMBL17810057 | 0.78 | DUSP3 (0.46) | DUSP3KDM4EATML3MBTL1 | |
| SCHEMBL17810050 | 0.77 | DUSP3 (0.43) | DUSP3KDM4EATML3MBTL1ALKBH5 | |
| SCHEMBL17809990 | 0.77 | DUSP3 (0.41) | DUSP3KDM4EATML3MBTL1ALKBH5 | |
| SCHEMBL17810097 | 0.75 | DUSP3 (0.40) | DUSP3KDM4EATML3MBTL1ALKBH5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9502667-B2 | Organic electroluminescence | IDEMITSU KOSAN CO., LTD. (JP) | 2016-11-22 | — | — | US | disclosed |
| US-9502667-B2 | Organic electroluminescence | IDEMITSU KOSAN CO., LTD. (JP) | 2016-11-22 | — | — | US | disclosed |
| US-20160163998-A1 | ORGANIC ELECTROLUMINESCENCE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-09 | — | — | US | disclosed |
| US-20160163998-A1 | ORGANIC ELECTROLUMINESCENCE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160163998-A1 | ORGANIC ELECTROLUMINESCENCE | EML4, ODC1, NDC1 | DUSP3 4656/4885KDM4E 1066/4885ATM 3046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.